Herbal COVID-19 treatment trial pulled before it began

NCT ID NCT05552625

Terminated Symptom relief Sponsor: Helixmith Co., Ltd. Source: ClinicalTrials.gov ↗

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study planned to test TADIOS, a blend of three herbs used in traditional Asian medicine, as an add-on treatment for adults hospitalized with mild to moderate COVID-19. Participants would have received TADIOS or a placebo for up to 10 days. The goal was to see if TADIOS could improve recovery and reduce inflammation. However, the trial was withdrawn before enrolling anyone, so no results are available.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: TADIOS (a combination of three herbs traditionally used for respiratory issues in Asia)
What this could lead to: If it had worked, TADIOS might have helped reduce inflammation and speed recovery from mild to moderate COVID-19.
What could go wrong: The trial was withdrawn before any participants were enrolled, so no data on safety or effectiveness exist. Herbal supplements can vary in quality and may interact with other medications.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for COVID-19 are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

COVID-19

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

COVID-19

Contacts and locations

Locations

Chaitanya Hospital

Paravūr, Kerala, 683513, India
Gunjkar Multispeciality Hospital

Pune, Maharashtra, 4110019, India
Lakshmi Nursing Home

Kochi, Kerala, 683101, India
Oxycare Multispecialty Hospital

Pune, Maharashtra, 411033, India
Sparsh Superspeciality Hospital

Bangalore, Karnataka, 560022, India
Vagus Super Specialty Hospital

Bangalore, Karnataka, 560003, India

More trials for these conditions

Other studies related to the condition(s) this trial covers.